In vitro susceptibility of Candida dubliniensis to current and new antifungal agents
作者： Guillermo Quindós , Alfonso Javier Carrillo-Muñoz , María Pilar Arévalo , Javier Salgado , Rocío Alonso-Vargas
DOI: 10.1159/000007320
关键词:
摘要: Background: Candida dubliniensis is a recently described species closely related to albicans , which has been
cabdirect.org
karger.com 
sci-hub.se 参考文章(17)
Frank C. Odds, Luc Van Nuffel, Géry Dams, Prevalence of Candida dubliniensis Isolates in a Yeast Stock Collection Journal of Clinical Microbiology. ,vol. 36, pp. 2869- 2873 ,(1998) , 10.1128/JCM.36.10.2869-2873.1998
M. A. Pfaller, S. A. Messer, S. Gee, S. Joly, C. Pujol, D. J. Sullivan, D. C. Coleman, D. R. Soll, In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. Journal of Clinical Microbiology. ,vol. 37, pp. 870- 872 ,(1999) , 10.1128/JCM.37.3.870-872.1999
Michael R. McGinnis, Laboratory Handbook of Medical Mycology ,(1980)
David A. Stevens, Julie A. Stevens, Cross-resistance phenotypes of fluconazole-resistant Candida species: Results with 655 clinical isolates with different methods Diagnostic Microbiology and Infectious Disease. ,vol. 26, pp. 145- 148 ,(1996) , 10.1016/S0732-8893(96)00199-X
Ana Espinel-Ingroff, Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts Journal of Clinical Microbiology. ,vol. 36, pp. 2950- 2956 ,(1998) , 10.1128/JCM.36.10.2950-2956.1998
Vincent T. Andriole, Current and future antifungal therapy: new targets for antifungal agents Journal of Antimicrobial Chemotherapy. ,vol. 44, pp. 151- 162 ,(1999) , 10.1093/JAC/44.2.151
G P Moran, D J Sullivan, M C Henman, C E McCreary, B J Harrington, D B Shanley, D C Coleman, Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrobial Agents and Chemotherapy. ,vol. 41, pp. 617- 623 ,(1997) , 10.1128/AAC.41.3.617
A. J. Carrillo-Muñoz, G. Quindós, C. Tur, M. T. Ruesga, Y. Miranda, O. del Valle, P. A. Cossum, T. L. Wallace, In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole Journal of Antimicrobial Chemotherapy. ,vol. 44, pp. 397- 401 ,(1999) , 10.1093/JAC/44.3.397
G. D. Gilfillan, D. J. Sullivan, K. Haynes, T. Parkinson, D. C. Coleman, N. A. R Gow, Candida dubliniensis: phylogeny and putative virulence factors Microbiology. ,vol. 144, pp. 829- 838 ,(1998) , 10.1099/00221287-144-4-829
D Sullivan, K Haynes, J Bille, P Boerlin, L Rodero, S Lloyd, M Henman, D Coleman, Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. Journal of Clinical Microbiology. ,vol. 35, pp. 960- 964 ,(1997) , 10.1128/JCM.35.4.960-964.1997